![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Frampton James E.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.72, Iss.15, 2012-10, pp. : 1999-2011
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Cazzola Mario Rogliani Paola Matera Maria Gabriella
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Indacaterol: In Chronic Obstructive Pulmonary Disease
Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Roflumilast: In Chronic Obstructive Pulmonary Disease
By Sanford Mark
Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetics of chronic obstructive pulmonary disease
Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. :